Open AccessImmunomodulation and COVID-19: Is There a Winning Combination?
Author(s) -
Srinivas Samavedam
Publication year - 2020
Publication title -
indian journal of critical care medicine/indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.5005/jp-journals-10071-23691
Subject(s) - medicine , covid-19 , intensive care medicine , pharmacotherapy , coronavirus , coronavirus infections , pandemic , virology , disease , infectious disease (medical specialty) , outbreak
Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine, Mahale et al. retrospectively evaluated a combination of drugs targeted at immunomodulation.